Yoshiyasu Okuhara
Overview
Explore the profile of Yoshiyasu Okuhara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mitani K, Horino T, Terada Y, Okuhara Y, Hatakeyama Y
Clin Exp Nephrol
. 2024 Nov;
29(3):283-291.
PMID: 39579299
Background: The involvement of monoclonal immunoglobulin (MIg) in renal damage in patients with haematological disorders and renal biopsy-proven monoclonal gammopathy of renal significance is well established. However, no epidemiological studies...
2.
Yasui S, Horino T, Mitani K, Terada Y, Okuhara Y, Hatakeyama Y
Clin Exp Nephrol
. 2024 Sep;
29(1):83-90.
PMID: 39331318
Background: Urinary creatinine levels are used to estimate the excretion rates of certain analytes from the respective analyte-to-creatinine ratios. We clarified the influence of age and sex on estimated daily...
3.
Hatakeyama Y, Horino T, Yasui S, Terada Y, Okuhara Y
Clin Exp Nephrol
. 2024 May;
28(11):1097-1110.
PMID: 38814420
Background: Few epidemiologic studies on acute kidney injury (AKI) have focused on the older adult population. This study aimed to clarify the characteristics and risk factors for AKI in this...
4.
Hyohdoh Y, Hiyama M, Hatakeyama Y, Okuhara Y
Arch Gerontol Geriatr
. 2023 Dec;
118:105315.
PMID: 38128267
Objectives: This study investigated the association between hyponatremia and falls in elderly hospitalized patients, focusing on mild hyponatremia as a potential risk factor. Materials And Methods: A retrospective analysis of...
5.
Hatakeyama Y, Horino T, Yasui S, Komori M, Terada Y, Okuhara Y
Clin Exp Nephrol
. 2022 Dec;
27(3):262-271.
PMID: 36574103
Background: The epidemiology of renal impairment in patients with cancer remains unclear. We aimed to clarify associations between various cancer sites and renal impairment. Methods: We reviewed data from 5674...
6.
Fukuhara H, Nohara T, Nishimoto K, Hatakeyama Y, Hyodo Y, Okuhara Y, et al.
BMC Cancer
. 2021 Nov;
21(1):1223.
PMID: 34774000
Background: To investigate risk factors for orally administered 5-aminolevulinic acid (ALA)-induced hypotension for bladder cancer patients receiving photodynamic diagnosis (PDD)-assisted transurethral resection of bladder tumor (TURBT). Methods: Patients were categorized...
7.
Hatakeyama Y, Horino T, Matsumoto T, Terada Y, Okuhara Y
Clin Exp Nephrol
. 2021 Jun;
25(10):1087-1092.
PMID: 34089392
Background: Proton-pump inhibitors (PPIs) are widely used to treat gastroesophageal reflex disease, peptic ulcer disease, and stress ulcer prophylaxis. This study estimated the progress rate of renal dysfunction in patients...
8.
Nagata K, Horino T, Hatakeyama Y, Matsumoto T, Terada Y, Okuhara Y
Nephrology (Carlton)
. 2020 Nov;
26(4):312-318.
PMID: 33207040
Aim: To clarify the effects of the duration of acute damage and/or loss of renal function following an acute kidney injury event on the renal prognosis after recovery. Methods: We...
9.
Yatabe T, Karashima T, Kume M, Kawanishi Y, Fukuhara H, Ueba T, et al.
JA Clin Rep
. 2020 May;
6(1):35.
PMID: 32399904
Background: 5-Aminolevulinic acid (5-ALA) is useful as a photodynamic agent, but its use commonly leads to hypotension. Although avoiding a mean arterial pressure (MAP) < 60 mmHg is important, the...
10.
Watanabe S, Kawano T, Horino T, Matsumoto T, Nagata K, Hatakeyama Y, et al.
BMC Res Notes
. 2019 Nov;
12(1):756.
PMID: 31752990
Objective: Hyperuricemia has been reported to be associated with the development of postoperative acute kidney injury (pAKI). However, it remains underdetermined whether hyperuricemia treatment could decrease the potential risk of...